FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:2023-2024 December 31, 1998 Number 27 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Besarab, A.

To the Editor: In their assessment of normal as compared with low hematocrit values in patients with cardiac disease who were undergoing hemodialysis and receiving epoetin, Besarab et al. (Aug. 27 issue)¹ report seemingly paradoxical results. Although the mortality rate among the patients assigned to the normal-hematocrit group was higher than that among those in the low-hematocrit group, within each group, the mortality rate decreased with increasing hematocrit values.

The authors point out that these disparate outcomes are not explained by differences in base-line demographic and clinical characteristics or laboratory values or by differences in the dose of epoetin, and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.